GT Biopharma Inc (GTBP)
3.12
-0.15
(-4.59%)
USD |
NASDAQ |
May 17, 16:00
3.83
+0.71
(+22.76%)
After-Hours: 20:00
GT Biopharma Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2019 | 0.00 |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 0.00 |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.02M |
| March 31, 2015 | 0.007M |
| December 31, 2014 | -0.002M |
| September 30, 2014 | -0.002M |
| June 30, 2014 | 0.008M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.019M |
| September 30, 2013 | 0.06M |
| June 30, 2013 | 0.044M |
| March 31, 2013 | 0.019M |
| Date | Value |
|---|---|
| December 31, 2012 | 0.158M |
| September 30, 2012 | 0.088M |
| June 30, 2012 | 0.001M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.003M |
| September 30, 2011 | -0.006M |
| June 30, 2011 | -0.014M |
| March 31, 2011 | -0.005M |
| December 31, 2010 | -0.054M |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | -0.013M |
| September 30, 2009 | -0.003M |
| June 30, 2009 | 0.015M |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.058M |
| September 30, 2008 | -0.077M |
| June 30, 2008 | 0.14M |
| March 31, 2008 | 0.112M |
| December 31, 2007 | 0.306M |
| September 30, 2007 | 0.78M |
| June 30, 2007 | 1.04M |
| March 31, 2007 | 0.662M |
| December 31, 2006 | 0.685M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Cutera Inc | 12.42M |
| Outlook Therapeutics Inc | -- |
| 180 Life Sciences Corp | -- |
| Journey Medical Corp | 6.214M |
| NovaBay Pharmaceuticals Inc | 1.794M |